DE69524981T2 - Pharmazeutische Zubereitungen enthaltend Raloxifen, einen oberflächenaktiven Stoff und ein wasserlösliches Verdünnungsmittel - Google Patents

Pharmazeutische Zubereitungen enthaltend Raloxifen, einen oberflächenaktiven Stoff und ein wasserlösliches Verdünnungsmittel

Info

Publication number
DE69524981T2
DE69524981T2 DE69524981T DE69524981T DE69524981T2 DE 69524981 T2 DE69524981 T2 DE 69524981T2 DE 69524981 T DE69524981 T DE 69524981T DE 69524981 T DE69524981 T DE 69524981T DE 69524981 T2 DE69524981 T2 DE 69524981T2
Authority
DE
Germany
Prior art keywords
surfactant
water
pharmaceutical preparations
preparations containing
soluble diluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69524981T
Other languages
English (en)
Other versions
DE69524981D1 (de
Inventor
Lowell Lee Gibson
Kerry John Hartauer
Julian Larry Stowers
Stephanie Ann Sweetana
Arvind Lavji Thakkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Europe GmbH
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69524981D1 publication Critical patent/DE69524981D1/de
Publication of DE69524981T2 publication Critical patent/DE69524981T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
DE69524981T 1994-03-02 1995-02-28 Pharmazeutische Zubereitungen enthaltend Raloxifen, einen oberflächenaktiven Stoff und ein wasserlösliches Verdünnungsmittel Expired - Lifetime DE69524981T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20491594A 1994-03-02 1994-03-02
SG1997000220A SG65636A1 (en) 1994-03-02 1997-01-30 Orally administrable pharmaceutical formulations

Publications (2)

Publication Number Publication Date
DE69524981D1 DE69524981D1 (de) 2002-02-21
DE69524981T2 true DE69524981T2 (de) 2002-08-29

Family

ID=26665140

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69524981T Expired - Lifetime DE69524981T2 (de) 1994-03-02 1995-02-28 Pharmazeutische Zubereitungen enthaltend Raloxifen, einen oberflächenaktiven Stoff und ein wasserlösliches Verdünnungsmittel

Country Status (22)

Country Link
EP (1) EP0670162B1 (de)
JP (1) JP3574210B2 (de)
CN (1) CN1098684C (de)
AT (1) ATE211910T1 (de)
AU (1) AU684882B2 (de)
BR (1) BR9500758A (de)
CA (1) CA2143263C (de)
CZ (1) CZ286119B6 (de)
DE (1) DE69524981T2 (de)
DK (1) DK0670162T3 (de)
ES (1) ES2166799T3 (de)
FI (1) FI117042B (de)
HU (1) HU225418B1 (de)
IL (1) IL112746A (de)
NO (1) NO314286B1 (de)
NZ (1) NZ270588A (de)
PL (1) PL178858B1 (de)
PT (1) PT670162E (de)
RU (1) RU2118540C1 (de)
SG (1) SG65636A1 (de)
SI (1) SI0670162T1 (de)
ZA (1) ZA951497B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CA2223595C (en) 1995-06-07 2008-08-05 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
EP0910369B1 (de) * 1996-03-26 2010-04-21 Eli Lilly And Company Benzothiophene und denen enthaltende zusammensetzungen
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
YU42397A (sh) * 1996-10-30 2000-10-30 Eli Lilly And Company Korišćenje raloksifena za pripremu leka
ZA979720B (en) 1996-10-30 1999-04-29 Lilly Co Eli Prophylaxis of breast cancer
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
JP4798924B2 (ja) * 1999-12-13 2011-10-19 中外製薬株式会社 ヒドロキシカルボニル−ハロゲノアルキル側鎖を有する化合物
KR100576149B1 (ko) 1999-12-13 2006-05-03 추가이 세이야쿠 가부시키가이샤 하이드록시카보닐-할로게노알킬 측쇄를 갖는 화합물
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
CZ20033119A3 (cs) * 2001-04-24 2005-01-12 Merck Patent Gmbh Kombinovaná terapie za použití antiangiogenových činidel a TNF alfa
CA2499819A1 (en) 2002-09-30 2004-04-08 A/S Gea Farmaceutisk Fabrik Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
US20050008704A1 (en) * 2003-07-11 2005-01-13 Ray Anup Kumar Pharmaceutical composition for solubility enhancement of hydrophobic drugs
CA2653384C (en) 2006-06-30 2017-03-14 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
US20110065751A1 (en) * 2007-10-16 2011-03-17 Pharmathen S.A. Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof
CL2008003799A1 (es) * 2007-12-21 2009-12-18 Synthon Bv Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis.
AU2010239081C1 (en) 2009-04-24 2014-11-06 Iceutica Pty Ltd A novel formulation of indomethacin
WO2011000581A2 (en) 2009-07-02 2011-01-06 Synthon B.V. Raloxifene composition
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
CN103006570B (zh) * 2012-10-08 2013-12-25 孙维会 一种阿佐昔芬速释微丸及其制备方法
ES2864096T3 (es) 2012-11-30 2021-10-13 Pharmathen Sa Método nuevo para mejorar la biodisponibilidad de fármacos de baja solubilidad acuosa
CN103830197A (zh) * 2014-03-14 2014-06-04 崔书豪 一种盐酸雷洛昔芬分散片及其制备方法
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
KR102612983B1 (ko) * 2016-09-30 2023-12-13 한미약품 주식회사 용출율이 향상된 라록시펜, 및 비타민 d 또는 그 유도체를 포함하는 복합 캡슐제 및 이의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Also Published As

Publication number Publication date
CZ286119B6 (cs) 2000-01-12
JPH07277973A (ja) 1995-10-24
DK0670162T3 (da) 2002-03-11
SI0670162T1 (en) 2002-06-30
FI117042B (fi) 2006-05-31
HUT72661A (en) 1996-05-28
CZ49995A3 (en) 1995-10-18
FI950947A (fi) 1995-09-03
ZA951497B (en) 1996-08-23
EP0670162B1 (de) 2002-01-16
NO950799L (no) 1995-09-04
DE69524981D1 (de) 2002-02-21
EP0670162A1 (de) 1995-09-06
FI950947A0 (fi) 1995-03-01
CA2143263C (en) 2002-01-08
NZ270588A (en) 1996-01-26
NO950799D0 (no) 1995-03-01
PT670162E (pt) 2002-06-28
BR9500758A (pt) 1995-10-24
ATE211910T1 (de) 2002-02-15
HU225418B1 (en) 2006-11-28
AU1354895A (en) 1995-09-07
IL112746A0 (en) 1995-05-26
PL178858B1 (pl) 2000-06-30
CA2143263A1 (en) 1995-09-03
CN1098684C (zh) 2003-01-15
ES2166799T3 (es) 2002-05-01
JP3574210B2 (ja) 2004-10-06
RU2118540C1 (ru) 1998-09-10
SG65636A1 (en) 1999-06-22
HU9500635D0 (en) 1995-04-28
PL307491A1 (en) 1995-09-04
NO314286B1 (no) 2003-03-03
IL112746A (en) 1999-12-31
AU684882B2 (en) 1998-01-08
CN1112420A (zh) 1995-11-29

Similar Documents

Publication Publication Date Title
DE69524981T2 (de) Pharmazeutische Zubereitungen enthaltend Raloxifen, einen oberflächenaktiven Stoff und ein wasserlösliches Verdünnungsmittel
DK0698393T3 (da) 3-/-menthoxypropan-1,2-diol som solubiliseringsmiddel og præparat til udvortes brug, der indeholder samme
GB2341801B (en) Formulation
DK0399902T3 (da) Porøs farmaceutisk tilberedningsform og fremstilling deraf
DK0642530T3 (da) Dolastatinderivater
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
NO913035D0 (no) (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.
ATE149360T1 (de) Zahnseide mit chemotherapeutischen wirkstoffen
SE9101687L (sv) Dikloranilinfoerening
NO901169L (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.
MY117590A (en) Orally administerable pharmaceutical formulations
ITRM930085A0 (it) Tensioattivi poco schiumogeni, loro preparazione e loro impiego in procedimenti di tintura. (caso 150-5603)
ITPR910054A0 (it) Miscelatore per autorespiratore ad uso medicale,particolarmente per camera iperbarica.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN

R082 Change of representative

Ref document number: 670162

Country of ref document: EP

Representative=s name: GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH, 805

R082 Change of representative

Ref document number: 670162

Country of ref document: EP

Representative=s name: GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH, DE

R081 Change of applicant/patentee

Ref document number: 670162

Country of ref document: EP

Owner name: DAIICHI SANKYO EUROPE GMBH, DE

Free format text: FORMER OWNER: ELI LILLY AND CO., INDIANAPOLIS, US

Effective date: 20120918

R082 Change of representative

Ref document number: 670162

Country of ref document: EP

Representative=s name: GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH, DE

Effective date: 20120918